Doseology Sciences Inc. (DOSEF)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 873.45 Thousand CAD | -47.64% |
| 2021 | 1.66 Million CAD | 6.44% |
| 2020 | 1.56 Million CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 131.66 Thousand CAD | 16.27% |
| 2023 Q1 | 113.24 Thousand CAD | -13.42% |
| 2022 FY | 873.45 Thousand CAD | -47.64% |
| 2022 Q3 | 152.99 Thousand CAD | -46.64% |
| 2022 Q2 | 286.73 Thousand CAD | -8.68% |
| 2022 Q1 | 313.98 Thousand CAD | -4.64% |
| 2022 Q4 | 130.79 Thousand CAD | -14.51% |
| 2021 Q3 | 525.7 Thousand CAD | 1.82% |
| 2021 Q1 | 296.96 Thousand CAD | -51.81% |
| 2021 Q2 | 516.32 Thousand CAD | 73.87% |
| 2021 Q4 | 329.27 Thousand CAD | -37.37% |
| 2021 FY | 1.66 Million CAD | 6.44% |
| 2020 Q4 | 616.18 Thousand CAD | 58.65% |
| 2020 Q3 | 388.4 Thousand CAD | -4.59% |
| 2020 Q2 | 407.08 Thousand CAD | 161.61% |
| 2020 Q1 | 155.6 Thousand CAD | 0.0% |
| 2020 FY | 1.56 Million CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 98.994% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 82.239% |
| SQZ Biotechnologies Company | 85.61 Million USD | 98.98% |
| Evofem Biosciences, Inc. | 29.55 Million USD | 97.044% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 97.656% |
| Mesoblast Limited | 5.9 Million USD | 85.201% |
| Propanc Biopharma, Inc. | 1.5 Million USD | 41.843% |
| Genus plc | 147.7 Million USD | 99.409% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | 90.051% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | 34.892% |
| Marizyme, Inc. | 19.23 Million USD | 95.46% |
| ContraFect Corporation | 56.88 Million USD | 98.465% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | 89.526% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | 80.188% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | 40.933% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | 70.048% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | 68.697% |
| MultiCell Technologies, Inc. | 567.42 USD | -153835.18% |
| Accustem Sciences Inc. | 3.74 Million USD | 76.685% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 98.984% |
| EV Biologics, Inc. | 531.96 Thousand USD | -64.196% |
| Q BioMed Inc. | 3.43 Million USD | 74.584% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 96.466% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -124.213% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | 66.757% |
| Biomind Labs Inc. | 994.18 Thousand USD | 12.143% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 225.49 Million USD | 99.613% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | 86.998% |
| Skye Bioscience, Inc. | 13.54 Million USD | 93.553% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | 57.365% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 3593.836% |
| Arch Therapeutics, Inc. | 5.04 Million USD | 82.676% |
| IMV Inc. | 37.7 Million USD | 97.684% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | 94.544% |
| Curative Biotechnology, Inc. | 1.83 Million USD | 52.403% |
| GB Sciences, Inc. | 1.42 Million USD | 38.511% |
| Alpha Cognition Inc. | 9.7 Million USD | 91.0% |
| HST Global, Inc. | 140.9 Thousand USD | -519.883% |
| CSL Limited | 3.44 Billion USD | 99.975% |
| Halberd Corporation | 74.84 Thousand USD | -1067.071% |
| Enzolytics Inc. | 2.17 Million USD | 59.924% |
| Resverlogix Corp. | 12.71 Million USD | 93.129% |
| Affymax, Inc. | 39.38 Million USD | 97.782% |
| SYBLEU INC | 160.87 Thousand USD | -442.939% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | 76.074% |
| argenx SE | 1.53 Billion USD | 99.943% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 98.479% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | 16.335% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | 44.695% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | 74.348% |
| AVAX Technologies, Inc. | 7.31 Million USD | 88.052% |
| Zenith Capital Corp. | 8.94 Million USD | 90.233% |
| Genscript Biotech Corporation | 825.34 Million USD | 99.894% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -4913.828% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | 64.426% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -409.279% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 99.121% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | 50.363% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 1.97 Million USD | 55.708% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | 53.15% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | 91.962% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | 54.529% |
| BioStem Technologies, Inc. | 22.97 Million USD | 96.198% |
| ONE Bio Corp. | 6.44 Million USD | 86.445% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -381.284% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | 34.593% |
| Wesana Health Holdings Inc. | 1.12 Million USD | 22.353% |
| Agentix Corp. | 1.37 Million USD | 36.325% |
| LadRx Corporation | 3.81 Million USD | 77.085% |
| Cell Source, Inc. | 4.32 Million USD | 79.806% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -110.229% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | 5.42% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | 5.42% |
| NovAccess Global Inc. | 2.46 Million USD | 64.591% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | 63.681% |
| Itoco Inc. | 919.14 Thousand USD | 4.97% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | 79.392% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | 21.943% |
| Kadimastem Ltd | 2.41 Million USD | 63.759% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -233.73% |
| CytoDyn Inc. | 18.05 Million USD | 95.163% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -3370.376% |
| Mobile Lads Corp. | 554.54 Thousand USD | -57.509% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -296.886% |
| Qrons Inc. | 643.67 Thousand USD | -35.698% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | 38.48% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 2.22 Million USD | 60.829% |
| Rebus Holdings, Inc. | 664 Thousand USD | -31.545% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | 51.911% |
| International Stem Cell Corporation | 5.27 Million USD | 83.429% |
| Bioxytran, Inc. | 3.82 Million USD | 77.135% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -1559.244% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -4193.659% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 97.592% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | 46.016% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -18.703% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | 71.924% |
| Neutra Corp. | 243.82 Thousand USD | -258.238% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | 94.997% |
| PureTech Health plc | 144.59 Million USD | 99.396% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | 95.737% |
| IXICO plc | 4.7 Million USD | 81.443% |
| IntelGenx Technologies Corp. | 8.79 Million USD | 90.071% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 99.258% |
| CSL Limited | 3.89 Billion USD | 99.978% |
| Cellectis S.A. | 97.32 Million USD | 99.102% |